Pacific Biosciences of California Inc (PACB) Unusual Options Activity Today

Checking PACB unusual options activity helps you spot when traders are making outsized bets on Pacific Biosciences of California Inc before the broader market catches on. Pacific Biosciences of California Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PACB unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PACB unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PACB unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PACB unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides.

The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Catalysts rarely arrive without a footprint, and PACB unusual options activity is often where that footprint shows up first. Our scanner tracks Pacific Biosciences of California Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PACB unusual options volume on the call side or chasing put sweeps, Pacific Biosciences of California Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.